No abstract available
MeSH terms
-
Age Factors
-
Antipsychotic Agents / adverse effects
-
Basal Ganglia Diseases / chemically induced*
-
Basal Ganglia Diseases / physiopathology
-
Basal Ganglia Diseases / prevention & control
-
Central Nervous System Stimulants / therapeutic use
-
Child
-
Diagnosis, Differential
-
Dose-Response Relationship, Drug
-
Dystonia Musculorum Deformans / chemically induced
-
Dystonia Musculorum Deformans / diagnosis
-
Dystonia Musculorum Deformans / drug therapy
-
Dystonia Musculorum Deformans / physiopathology
-
Dystonia Musculorum Deformans / prevention & control
-
Female
-
Humans
-
Male
-
Movement Disorders / chemically induced
-
Movement Disorders / prevention & control
-
Parasympatholytics / therapeutic use
-
Parkinson Disease, Secondary / chemically induced
-
Parkinson Disease, Secondary / drug therapy
-
Parkinson Disease, Secondary / physiopathology
-
Parkinson Disease, Secondary / prevention & control
-
Phenothiazines
-
Sex Factors
-
Tranquilizing Agents / adverse effects*
Substances
-
Antipsychotic Agents
-
Central Nervous System Stimulants
-
Parasympatholytics
-
Phenothiazines
-
Tranquilizing Agents